Entrepreneur Olivier Joy, who suffers from Charcot disease, raised 540,000 euros during a trip to San Francisco to accelerate medical research.
in france, Between 7,000 and 9,000 people live there Amyotrophic lateral sclerosis (amyotrophic lateral sclerosis)It is an acute neurological condition known as Charcot disease. In the face of this incurable condition,Lack of effective treatment Makes supporting scientific teams a priority. The latest initiative of a French transatlantic entrepreneur gives new impetus and opens new horizons for the development of future treatments.
Charcot disease gradually affects the nerve cells responsible for voluntary movements. Intellectual abilities generally remain preserved, making the gradual loss of motor functions particularly difficult for patients.
Silicon Valley rallies for amyotrophic lateral sclerosis
The choice of San Francisco responds to strategic logic. Olivier Joy crossed the Atlantic to challenge California’s leading tech innovators. This approach was born An impressive sum of 540,000 euros. The funds come from an unprecedented alliance between digital entrepreneurs, expatriate sponsors and local scientific experts. The enthusiasm generated by this trip went beyond borders, especially through the report broadcast on the 66 Minutes program on M6, amplifying this call for solidarity among French viewers.
A pioneering method against disease
The diagnosis falls in December 2020. The founder of the October platform decides to use the company’s tokens to support medicine. His management profile is a game-changer: he knows how to organize fundraising and impose a vision. He is physically engaged, even aware The parachute jump received much media coverage In order to promoteBrain Institute. Although the pathology changes the respiratory muscles, it is expressed throughVoice generated by artificial intelligenceAnd restore its original character to continue its public interventions.
Long-term science funding
The aim of this California group is to fund targeted research work. Scientific committees inBrain Institute (ICM) andThey sent Carefully choose the benefiting programs. Olivier Joy’s ambition goes beyond one-time donations. He created the “Invincible Summer” Endowment Fund, a financial mechanism designed to bring people together million euros annually And ensuring stable resources for laboratories.
Hope in clinical trials
The need for scientific innovation remains urgent. Every year, doctors determine About 1,000 new cases of ALS on national territory. The provision of enormous financial resources makes it possible to scale up clinical trials and test new neuroprotective molecules. This permanent structure of care provides researchers with the financial visibility needed to explore promising genetic pathways to and reverse these neurodegenerative diseases.
Why is research so difficult?
Amyotrophic lateral sclerosis remains one of the most complex neurological diseases that can be treated. Researchers are still struggling to determine the exact mechanisms responsible for the progressive destruction of motor neurons. This difficulty explains why therapeutic progress remains slow despite decades of international research.
An illness that also affects loved ones
Beyond its physical consequences, ALS profoundly disrupts family life. The gradual loss of independence often increases the need for daily assistance. Patient associations point out that psychological support for loved ones is also a major issue in care.
